CV autonomic neuropathy predicts urological issues

May 21, 2015
CV autonomic neuropathy predicts urological issues

(HealthDay)—For men with type 1 diabetes, cardiovascular autonomic neuropathy is associated with erectile dysfunction and/or lower urinary tract symptoms, according to a study published in the June issue of The Journal of Urology.

Rodica Pop-Busui, M.D., Ph.D., from the University of Michigan in Ann Arbor, and colleagues examined the correlation between cardiovascular autonomic neuropathy and erectile dysfunction and/or lower urinary tract symptoms. Data were obtained for 635 men in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) with . Analyses were adjusted for time-weighted glycemic control, blood pressure, age, and other covariates.

The researchers found that, compared to men without erectile dysfunction or lower urinary tract symptoms, those with erectile dysfunction and/or lower urinary tract symptoms had significantly lower respiratory rate variation and Valsalva ratio at DCCT closeout and EDIC year 16/17. The odds of and lower were increased 2.65-fold among participants with cardiovascular autonomic neuropathy, in adjusted analysis.

"These data suggest that cardiovascular autonomic neuropathy predicts the development of urological complications in men with long-standing type 1 diabetes," the authors write. "Studies evaluating the mechanisms contributing to these interactions are warranted for targeting effective prevention or treatment."

One author disclosed financial ties to the medical device industry.

Explore further: Study highlights benefits of screening for heart disease in men with erectile dysfunction

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Study highlights benefits of screening for heart disease in men with erectile dysfunction

March 2, 2015
New research reveals that screening for cardiovascular disease in men presenting with erectile dysfunction may be a cost-effective intervention for preventing both cardiovascular disease and, over the longer term, erectile ...

Testosterone therapy doesn't worsen urinary symptoms

November 25, 2013
(HealthDay)—For hypogonadal men, testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms, according to a study published in the November issue of The Journal of Urology.

Weight loss improves sexual health of overweight men with diabetes

August 5, 2011
A new study published in The Journal of Sexual Medicine reveals that in obese men with type 2 diabetes, weight loss improves erectile function, sexual desire and lowers urinary tract symptoms.

Erectile dysfunction drug relieves nerve damage in diabetic mice

March 17, 2015
New animal studies at Henry Ford Hospital found that sildenafil, a drug commonly used to treat erectile dysfunction, may be effective in relieving painful and potentially life-threatening nerve damage in men with long-term ...

Early detectable vascular disease linked to erectile dysfunction

November 18, 2014
Men who have asymptomatic subclinical vascular disease are more likely to develop erectile dysfunction than men who don't have early stage vascular disease, according to research presented at the American Heart Association's ...

High prevalence of undisclosed neuropathy in diabetic patients

May 6, 2015
A survey of 25,000 Romanians with diabetes has revealed that diabetic neuropathy (DN), a complication of diabetes, is highly prevalent in these patients, even in the absence of a diagnostic, and has an important impact on ...

Recommended for you

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.